Oncternal Therapeutics, Inc. - COM NEW (ONCT)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
357K
Holdings value Q3 2024
$471K
Value change Q3 2024
-$690K
Grand Portfolio weight change Q3 2024
0%
Number of holders
21
Number of buys Q3 2024
7
Number of sells Q3 2024
-10
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 357K $471K -$690K $1.32 21
2024 Q2 483K $3.67M +$248K $7.60 26
2024 Q1 450K $4.05M +$3.97M $9.00 24
2023 Q4 59K $31.7K +$31.7K $0.54 4